ChemotherapyAdvisor.com is Now Live

NEW YORK, Jan. 23, 2012 /PRNewswire/ -- Haymarket Media Inc., publisher of Monthly Prescribing Reference (MPR), MPR Hematology/Oncology Edition, and Oncology Nurse Advisor (ONA), is pleased to announce the launch of ChemotherapyAdvisor.com, offering oncologists and their support teams a unique clinical decision support tool.

ChemotherapyAdvisor.com is designed to empower oncology professionals to make informed treatment decisions.  The site provides practice-focused and comprehensive clinical and drug information reflecting best current practices and emerging trends in cancer treatment.

ChemotherapyAdvisor.com offers quick and easy access to:

• Current cancer treatment drug regimens
• Concise MPR drug monographs organized by tumor type
• Extensive clinical trial information
• Updated evidence-based oncology guidelines
• Relevant clinical charts and calculators
• Live and archived coverage of major oncology conferences
• Practical oncology nursing content
• Daily news updates
• Continuing education activities

Thirty interactive treatment regimen charts serve as the centerpiece of the site, with links to MPR concise drug monographs, listings of relevant dosing information, and access to comprehensive clinical trial information.  In addition, the site provides the latest information on emerging agents awaiting FDA approval and their role in current therapy, as well as relevant issues shaping the oncology market.

In recognizing that oncology health-care professionals often specialize in the treatment of a particular tumor type, ChemotherapyAdvisor.com is organized by major types of cancer, to give specialists easy access to the information they are looking for.

ChemotherapyAdvisor.com is served by an editorial advisory board of recognized oncology experts, who provide guidance regarding content selection and help ensure that the site is timely, relevant, and immediately useful for their peers. The board includes clinicians from renowned cancer institutions such as Memorial Sloan-Kettering Cancer Center, Mayo Clinic, Vanderbilt University Medical Center, and UPMC Cancer Center.

"ChemotherapyAdvisor.com really changes the landscape as a single resource for drug information and chemotherapy regimens pertaining to the treatment of patients with a wide spectrum of cancers," said Todd Morgan, MD, Assistant Professor, Department of Urologic Surgery, Vanderbilt University Medical Center. "The site is extremely well organized, providing clear and concise information that will be extremely useful for any oncology-based practice."

Lee Maniscalco, CEO, Haymarket Media Inc. affirms, "ChemotherapyAdvisor.com is an important part of Haymarket's ongoing and expanding commitment to the oncology community. The world of cancer care is rapidly changing, as new data are published, new treatment protocols are developed, and new guidelines are issued. Our pledge is to equip the entire oncology team with the latest and best information to help ensure optimal patient care."

About Haymarket Media, Inc. and MPR

Haymarket Media Inc. (HMI) is a global publication and communications company, with operations on five continents. Founded in 1957 and headquartered in the United Kingdom, HMI publishes titles in 23 languages in more than 100 nations. In the United States HMI publishes, among other health-care journals, the Monthly Prescribing Reference (MPR), the MPR Hematology-Oncology Edition, and Oncology Nurse Advisor. Since 1985, MPR has been the most widely used drug reference by health-care professionals in a wide variety of specialties and practice settings. 

SOURCE Haymarket Media